Article
A Phase I, single and continuous administration study of Safety, tolerability and pharmacokinetics of neorudin, a noval recombinant anticoagulant protein, in healthy subjects
2024-01-30
Abstract excerpt
AIMS: The aims of the study were to evaluate the tolerability, safety and pharmacokinetics of single and continuous administration of recombinant neorudin (EPR-hirudin, EH) by intravenous injection in healthy subjects, and to provide a safe dosage range for phase II clinical research. METHODS: A single and continuous administration dose phase I clinical study was conducted. Forty-four subjects were received EH as...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ee29f139-d659-553f-87db-4435cc782ee8
- DOI
- 10.22541/au.170664618.84732094/v1
